Samsung Biologics Collaborates with Dinona to Develop DNP-019 for COVID-19

October 21, 2020 Auto Bot Collaborates, Develop, Pharma, Samsung Biologics 0

Shots:

  • The companies collaborate for fast-track development of DNP-019 against COVID-19
  • The collaboration will expand Samsung’s CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing
  • Samsung has introduced its proprietary cell-line technology, S-CHOice, demonstrating improved titers up to two-fold and maintaining over 90% cell viability

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Twitter

The post Samsung Biologics Collaborates with Dinona to Develop DNP-019 for COVID-19 first appeared on PharmaShots.